Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 3 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Gilteritinib-based combination therapy in adult relapsed/refractory FLT3-mutated acute myeloid leukaemia.
Br J Haematol. 2024 Mar;204(3):861-870. doi: 10.1111/bjh.19182. Epub 2023 Nov 8.
Br J Haematol. 2024.
PMID: 37939390
Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients.
Zhou Z, Zhuo N, Zhou Y, Sun C, Yao Y, Mao L, Zhang Y, Hong Q, Pan P, Tong H, Jin J, Wang H.
Zhou Z, et al.
Am J Hematol. 2024 Jul;99(7):1441-1444. doi: 10.1002/ajh.27340. Epub 2024 Apr 23.
Am J Hematol. 2024.
PMID: 38651500
No abstract available.
Item in Clipboard
Phosphoproteomic Characterization and Kinase Signature Predict Response to Venetoclax Plus 3+7 Chemotherapy in Acute Myeloid Leukemia.
Jin J, Hou S, Yao Y, Liu M, Mao L, Yang M, Tong H, Zeng T, Huang J, Zhu Y, Wang H.
Jin J, et al.
Adv Sci (Weinh). 2024 Mar;11(11):e2305885. doi: 10.1002/advs.202305885. Epub 2023 Dec 31.
Adv Sci (Weinh). 2024.
PMID: 38161214
Free PMC article.
Item in Clipboard
Cite
Cite